Should add in more information than that - at least summarise what caused revenue to decrease and what caused losses to increase.
Revenues down, marginally - not unexpected given COVID impact globally, but we're still doing well and have strong partnerships.
Losses increased, by ~$2m - due to a one off impairment as we're expanding to Gen 2, which is in line with accounting treatment as things get decommissioned and no longer required.
- Forums
- ASX - By Stock
- Ann: Appendix 4D and Half Year Report
Should add in more information than that - at least summarise...
Featured News
Add NVX (ASX) to my watchlist
(20min delay)
|
|||||
Last
88.0¢ |
Change
0.060(7.32%) |
Mkt cap ! $434.4M |
Open | High | Low | Value | Volume |
82.5¢ | 93.0¢ | 82.5¢ | $6.028M | 6.832M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6553 | 87.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 18999 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6553 | 0.875 |
2 | 23500 | 0.870 |
6 | 51800 | 0.865 |
10 | 212507 | 0.860 |
4 | 103908 | 0.855 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 18999 | 2 |
0.885 | 15000 | 1 |
0.890 | 10000 | 1 |
0.895 | 52783 | 1 |
0.900 | 132225 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NVX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online